Detection of telomerase activity in prostate needle-biopsy samples

Prostate

Volumn 36, Issue 2, 1998, Pages 121-128

  Lin, Yi ^a   Uemura, Hiroji ^a   Fujinami, Kiyoshi ^a   Hosaka, Masahiko ^a   Iwasaki, Yoshiko ^b   Kitamura, Hitoshi ^a   Harada, Masaoki ^c   Kubota, Yoshinobu ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

Author keywords

Biopsy; Prostate cancer; Telomerase; TRAP assay

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CELL IMMORTALIZATION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; STATISTICAL ANALYSIS;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; DNA; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERASE;

EID: 0031836027     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980701)36:2<121::AID-PROS7>3.0.CO;2-L     Document Type: Article

References (25)

1. Ring K, Karp F, Olsson C, O'Toole K, Bixon R, Benson M: Flow cytometric analysis of localized adenocarcinoma of the prostate: The use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropublic prostatectomy. Prostate 1990;17:155-164.
2. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Lee C: Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 1996;2:1255-1261.
3. Asgare K, Sesterhenn IA, McLeod DG, Cowan K, Moul JW, Seth P, Srivastava S: Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector. Int J Cancer 1997;71:377-382.
4. Dahiya R, McCarville J, Hu W, Lee C, Chui RM, Kaur G, Deng G: Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int J Cancer 1997;71:20-25.
5. Meyne J, Ratliff RL, Moyzis RK: Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci USA 1989;86:7049-7053.
6. Morin GB: The human telomerase terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;49:521-529.
7. Blackburn EH: Structure and function of telomeres. Nature 1991;350:569-573.
8. Zakian VA: Structure and function of telomeres. Annu Rev Genet 1989;23:579-604.
9. Zakian VA: Telomeres: Beginning to understand the end. Science 1995;270:1601-1607.
10. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
11. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
12. Breslow RA, Shay JW, Gazdar AF, Srivastava S: Telomerase and early detection of cancer: A National Cancer Institute workshop. J Natl Cancer Inst 1997;89:618-623.
13. Counter M, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-2904.
14. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyzek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-255.
15. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-2536.
16. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y: Telomerase activity in human bladder cancer. Clin Cancer Res 1996;2:929-932.
17. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova S, Shay JW, Coffey DS: Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-222.
18. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y: Telomerase activity in primary prostate cancer. J Urol 1996;157:1161-1165.
19. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-122.
20. Tahara H, Nakanishi Y, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide Y: Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res 1995;55:2734-2736.
21. Wright WE, Shay JW, Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-3795.
22. Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, Ide T, Tahara E: Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995;1:1245-1251.
23. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
24. Catalona WJ, Smith DS: Comparison of different serum prostate specific antigen measures for early prostate cancer detection. Cancer 1994;74:1516-1518.
25. Kurita Y, Ushiyama T, Suzuki K, Fujita K, Kawabe K: PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer. Int J Urol 1996;3:367-372.